Insulin Guidelines for Gestational Diabetes Mellitus

Initial Management Approach

• The American Diabetes Association recommends insulin as the preferred first-line pharmacologic agent for Gestational Diabetes Mellitus (GDM) when lifestyle modifications fail to achieve glycemic targets within 1-2 weeks 1
• Approximately 70-85% of women with GDM can achieve adequate glycemic control through medical nutrition therapy, exercise, and glucose monitoring alone, making insulin unnecessary for the majority, as suggested by the American Diabetes Association 1

Glycemic Targets for Treatment Decisions

• The American College of Obstetricians and Gynecologists (ACOG) suggests alternative targets for blood glucose levels, including fasting <90 mg/dL, preprandial <105 mg/dL, 1-hour postprandial <130-140 mg/dL, and 2-hour postprandial <120 mg/dL, in cases where hypoglycemia occurs with stricter goals 1
• The American Diabetes Association recommends a 2-hour postprandial blood glucose target of <120 mg/dL 1

Insulin Initiation and Dosing

• The American Diabetes Association recommends using a basal-bolus regimen with a greater proportion as prandial insulin and smaller proportion as basal insulin for GDM management 1
• Insulin dose increases are expected weekly or biweekly during the second trimester due to rapidly increasing insulin resistance from diabetogenic placental hormones, as stated by the American Diabetes Association 1

Insulin Safety Profile

• All insulins are pregnancy category B except glargine and glulisine (category C), according to the American Diabetes Association 1
• Despite the classification difference, insulin remains the preferred agent over oral medications due to lack of long-term safety data for noninsulin agents in pregnancy, as recommended by the American Diabetes Association 1

Monitoring Requirements

• The American Diabetes Association recommends an A1C target of <6% if achievable without hypoglycemia for women with GDM 1
• Monthly A1C monitoring is recommended due to altered red blood cell kinetics during pregnancy, as suggested by the American Diabetes Association 1
• A1C should be used as a secondary measure alongside self-monitoring, as it may not fully capture physiologically relevant glycemic parameters in pregnancy, according to the American Diabetes Association 1

Referral Considerations

• Referral to a specialized center is recommended if available due to the complexity of insulin management in pregnancy, including frequent titration needs and changing insulin requirements across trimesters, as stated by the American Diabetes Association 1

Common Pitfalls to Avoid

• The American Diabetes Association recommends not using fixed insulin doses, as pregnancy physiology demands frequent adjustments, particularly during the second trimester when insulin resistance increases rapidly 1
• The American Diabetes Association suggests not relying solely on A1C for glucose management decisions, as self-monitoring of blood glucose provides more actionable real-time data for insulin adjustments 1

Postpartum Management

• Women with GDM require reevaluation with a 75g oral glucose tolerance test at 4-12 weeks postpartum, then ongoing diabetes screening every 1-3 years due to significantly increased risk of developing type 2 diabetes, as recommended by the American Diabetes Association 1

Diagnosis and Management of Gestational Diabetes

Diagnostic Criteria

• The International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria, adopted by the American Diabetes Association, diagnose gestational diabetes when any of the following values are met or exceeded during a 75g oral glucose tolerance test between 24-28 weeks of gestation: fasting ≥92 mg/dL, 1 hour ≥180 mg/dL, or 2 hours ≥153 mg/dL 2, 3
• The American College of Obstetricians and Gynecologists notes that a single elevated value can be used for diagnosis 2, 3, 4

Management

• The American Diabetes Association recommends immediate nutritional counseling for all women with gestational diabetes 5
• Objective glucose targets for women with gestational diabetes are: fasting <95 mg/dL, 1-hour postprandial <140 mg/dL, and 2-hour postprandial <120 mg/dL 6, 7
• The American College of Obstetricians and Gynecologists suggests that insulin therapy should be initiated if glucose levels are not maintained within the therapeutic range with lifestyle modifications 5
• Approximately 70-85% of women with gestational diabetes can achieve adequate control with lifestyle modifications alone 6

Monitoring and Follow-up

• Regular obstetric exams, including ultrasounds, are recommended for women with gestational diabetes 6
• The American College of Obstetricians and Gynecologists recommends that women with gestational diabetes be reevaluated 4-12 weeks postpartum with a 75g oral glucose tolerance test 4
• Women with a history of gestational diabetes have a 3.4 times higher risk of developing prediabetes and type 2 diabetes, and require lifelong screening for diabetes or prediabetes at least every 3 years 3, 4, 8

Insulin Initiation Criteria for Gestational Diabetes

Diagnostic Criteria

• The American Diabetes Association recommends a one-step approach (75g OGTT) for diagnosis, where only one elevated value is required among fasting ≥92 mg/dL, 1-hour ≥180 mg/dL, or 2-hour ≥153 mg/dL 9, 10, 11
• The American Diabetes Association also recommends a two-step approach (100g OGTT), where at least two elevated values are required for diagnosis among fasting ≥95 mg/dL, 1-hour ≥180 mg/dL, 2-hour ≥155 mg/dL, or 3-hour ≥140 mg/dL 9, 12

Glycemic Targets for Treatment Decisions

• The American Diabetes Association recommends the following targets for maternal capillary glucose during home monitoring: fasting ≤95 mg/dL (5.3 mmol/L) 12, 13

Common Pitfalls to Avoid

• The American College of Obstetricians and Gynecologists notes that women with only one elevated OGTT value should not be assumed to need less aggressive monitoring, as the one-step diagnostic approach identifies women at increased risk regardless of how many values were elevated 10, 11
• Delaying insulin initiation beyond 1-2 weeks if targets are not met can increase risks of macrosomia, shoulder dystocia, and cesarean delivery, according to the American Journal of Obstetrics and Gynecology 10, 11, 14